A Study of mDCF in Combination or Not With Atezolizumab in Advanced Squamous Cell Anal Carcinoma

NCT03519295 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

97

Enrollment

OTHER

Sponsor class

Conditions

Anal Cancer

Interventions

DRUG: MPDL3280A
DRUG: mDCF

Sponsor

GERCOR - Multidisciplinary Oncology Cooperative Group

Collaborators

[object Object]